JDEAX
Price
$42.51
Change
+$0.49 (+1.17%)
Updated
Mar 5 closing price
Net Assets
10.2B
VTSAX
Price
$139.88
Change
+$1.59 (+1.15%)
Updated
Mar 5 closing price
Net Assets
1.84T
Ad is loading...

JDEAX vs VTSAX

Header iconJDEAX vs VTSAX Comparison
Open Charts JDEAX vs VTSAXBanner chart's image
JPMorgan US Research Enhanced Equity A
Price$42.51
Change+$0.49 (+1.17%)
VolumeN/A
Net Assets10.2B
Vanguard Total Stock Mkt Idx Adm
Price$139.88
Change+$1.59 (+1.15%)
VolumeN/A
Net Assets1.84T
JDEAX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDEAX vs. VTSAX commentary
Mar 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDEAX is a Hold and VTSAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.84T vs. JDEAX (10.2B). VTSAX pays higher dividends than JDEAX: VTSAX (1.35) vs JDEAX (0.79). JDEAX was incepted earlier than VTSAX: JDEAX (23 years) vs VTSAX (24 years). JDEAX is a more actively managed with annual turnover of: 32.00 vs. VTSAX (2.00). JDEAX has a lower initial minimum investment than VTSAX: JDEAX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 12.85 vs. JDEAX (9.57). VTSAX return over 5 years is better than : 89.28 vs. JDEAX (74.64).
JDEAXVTSAXJDEAX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years24 years-
Gain YTD-0.793-1.94341%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets10.2B1.84T1%
Annual Yield % from dividends0.791.3559%
Returns for 1 year9.5712.8574%
Returns for 3 years30.9230.70101%
Returns for 5 years74.6489.2884%
Returns for 10 years92.12174.7553%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WAFU2.080.14
+7.22%
Wah Fu Education Group Limited
BCYC10.380.24
+2.37%
Bicycle Therapeutics plc
IKT2.230.03
+1.36%
Inhibikase Therapeutics
TEVA15.900.21
+1.34%
Teva Pharmaceutical Industries Limited
ZD38.17-0.91
-2.33%
Ziff Davis